Nasdaq
$10.25▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $92.7MShares out 9.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
1- 10.13Pre-market26.10.13 19:018-KKey event#●●●
IMMUCELL CORP /DE/Bullish
ImmuCell announced that its product sales for the third quarter of 2026 reached $8.0 million, representing a 46% increase compared to the same period in 2025. For the nine months ended September 30, 2026, total sales were $25.6 million, up 27.8% year-over-year, driven by sales team expansion and improved manufacturing capabilities. The company will discontinue early sales reporting and transition to standard quarterly financial disclosures.…more
$10.25+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
News
GlobeNewswire- 10.12After-hours26.10.13 05:25#●●●
ImmuCell Projects Q3 Sales of $8 Million
ImmuCell announced its revenue projection for the third quarter at $8 million. This guidance provides investors with an outlook on the company's expected quarterly performance.…more
$10.25+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.12After-hours26.10.13 05:05
●●●●●●●● ●●●●● ●●●●●●
ImmuCell announced preliminary third-quarter 2026 sales of $8.0 million, representing a 46% increase compared to the same period last year. The company noted that full financial metrics will be discussed during its scheduled conference call on November 13, 2026.…more
$10.25+0.00%vs prev close - 8.13After-hours26.08.14 05:05
●●●●●●●● ●●●●● ●●●●●●
ImmuCell reported a strong second quarter with revenue rising 11.5% to $7.2 million compared to the previous year. The company is investing $8 million to expand its manufacturing capacity to meet growing product demand.…more
$10.25+0.00%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report